Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intellectual Property

Intellectual Property

6 Months Ended

Feb. 28, 2019

On November 12, 2014, the Company signed an agreement with Poppy’s Teas LLC. (“PoViva”) whereby we acquired 51% of PoViva Tea LLC replacing Poppy’s Teas LLC. The Company acquired 100% ownership interest in PoViva Tea, LLC in October 2017 via compensation of $70,000, a waiver on certain debts owed to Lexaria, and a 5%, 20 year royalty on net profits of ViPova Tea^TM tea, coffee, and hot chocolate sales. No Lexaria stock or options were issued.

The following is a list of US capitalized patents held by the Company

Issued Patent #	Patent Issuance Date	Patent Family
US 9,474,725 B1	10/25/2016
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	5/15/2018	Food and Beverage Compositions Infused With
US 9,974,739 B2	5/22/2018	Lipophilic Active Agents and Methods of Use Thereof
US 10,084,044 B2	9/25/2018
US 10,103,225 B2	10/16/2018

Patents

	February 28 2019 $			August 31 2018 $
Balance – Beginning		146,538			62,827
Additions		55,743			85,399
Amortization*		(2,095	)		(1,688	)
Balance – Ending		200,186			146,538

* The patents are amortized over their legal life of 20 years.